日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A novel tool to predict lymph node metastasis in patients with prostate cancer based on clinical and 68Ga-PSMA PET/CT parameters

一种基于临床和 68Ga-PSMA PET/CT 参数预测前列腺癌患者淋巴结转移的新工具

Dekalo, Snir; Kuten, Jonathan; Bashi, Tomer; Savin, Ziv; Mano, Roy; Beri, Avi; Nevo, Amihay; Wasserman, Orel; Mabjeesh, Nicola J; Ziv-Baran, Tomer; Even-Sapir, Einat; Yossepowitch, Ofer

Neuromelanin and T(2)*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson's disease

神经黑色素和T(2)*-MRI用于评估有遗传风险、前驱期和症状性帕金森病

Ben Bashat, Dafna; Thaler, Avner; Lerman Shacham, Hedva; Even-Sapir, Einat; Hutchison, Matthew; Evans, Karleyton C; Orr-Urterger, Avi; Cedarbaum, Jesse M; Droby, Amgad; Giladi, Nir; Mirelman, Anat; Artzi, Moran

A sigh of relief: vaccine-associated hypermetabolic lymphadenopathy following the third COVID-19 vaccine dose is short in duration and uncommonly interferes with the interpretation of [(18)F]FDG PET-CT studies performed in oncologic patients

令人欣慰的是:接种第三剂新冠疫苗后出现的疫苗相关性高代谢性淋巴结病持续时间短,且很少干扰肿瘤患者进行的[(18)F]FDG PET-CT检查结果的解读。

Cohen, Dan; Hazut Krauthammer, Shir; Wolf, Ido; Even-Sapir, Einat

Head-to-head comparison of [(68)Ga]Ga-FAPI-04 and [(18)F]-FDG PET/CT in evaluating the extent of disease in gastric adenocarcinoma

在评估胃腺癌疾病范围方面,[(68)Ga]Ga-FAPI-04 与 [(18)F]-FDG PET/CT 的直接比较

Kuten, Jonathan; Levine, Charles; Shamni, Ofer; Pelles, Sharon; Wolf, Ido; Lahat, Guy; Mishani, Eyal; Even-Sapir, Einat

Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [(18)F]FDG PET-CT and relevance to study interpretation

接种 BNT162b2 mRNA Covid-19 疫苗后出现高代谢性淋巴结病:采用 [(18)F]FDG PET-CT 评估其发生率及其与研究结果解读的相关性

Cohen, Dan; Krauthammer, Shir Hazut; Wolf, Ido; Even-Sapir, Einat

Correlation between BNT162b2 mRNA Covid-19 vaccine-associated hypermetabolic lymphadenopathy and humoral immunity in patients with hematologic malignancy

BNT162b2 mRNA 新冠病毒疫苗相关高代谢性淋巴结病与血液系统恶性肿瘤患者体液免疫的相关性

Cohen, Dan; Hazut Krauthammer, Shir; Cohen, Yael C; Perry, Chava; Avivi, Irit; Herishanu, Yair; Even-Sapir, Einat

68Ga-PSMA-11 PET/CT Follow-Up of Patients with Prostate Cancer with Bone Metastases Who Had Reduced Bone Density after Androgen Deprivation Therapy

68Ga-PSMA-11 PET/CT 对接受雄激素剥夺疗法后骨密度降低的前列腺癌骨转移患者进行随访

Kesler, Mikhail; Druckmann, Ido; Levine, Charles; Kuten, Jonathan; Yossepowitch, Ofer; Even-Sapir, Einat

The significance of equivocal bone findings in staging PSMA imaging in the preoperative setting: validation of the PSMA-RADS version 1.0

术前PSMA影像分期中骨骼检查结果不明确的意义:PSMA-RADS 1.0版的验证

Kuten, Jonathan; Dekalo, Snir; Mintz, Ishai; Yossepowitch, Ofer; Mano, Roy; Even-Sapir, Einat

Personalized radiation dosimetry for PRRT-how many scans are really required?

PRRT治疗的个性化辐射剂量测定——究竟需要多少次扫描?

Freedman, Nanette; Sandström, Mattias; Kuten, Jonathan; Shtraus, Natan; Ospovat, Inna; Schlocker, Albert; Even-Sapir, Einat

[(68)Ga]Ga-PSMA-11 PET/CT for monitoring response to treatment in metastatic prostate cancer: is there any added value over standard follow-up?

[(68)Ga]Ga-PSMA-11 PET/CT 用于监测转移性前列腺癌的治疗反应:与标准随访相比,它是否有任何附加价值?

Kuten, Jonathan; Sarid, David; Yossepowitch, Ofer; Mabjeesh, Nicola J; Even-Sapir, Einat